Market Bizzz

Ola Electric Mobility’s shares are expected to be in focus on Monday following a significant drop in sales for November, which fell by over 33%, from 41,756 units in October to 27,746 units. Despite the decline, Ola maintained its position as the market leader with a 25.09% market share, although its margin over competitors TVS and Bajaj Auto has narrowed.

Cipla’s shares are likely to attract attention on Monday as the company’s promoters may sell up to a 1.72% stake through block deals. The offer price is expected to be set at Rs 1,442 per share, with the total block size estimated at Rs 2,000 crore.

A long buildup occurs when open interest and trading volumes increase alongside a rise in the underlying stock price in the Futures and Options segment, signaling a bullish market trend.

Sensex and Nifty movements this week will be influenced by several factors, including weak Q2 GDP data, auto sales figures, FII selling trends, and the upcoming RBI meeting. Other key considerations include technical analysis, geopolitical tensions, global economic data points, and crude oil prices. Analysts expect market sideways movements for the next 6-12 months.

FIIs sold Rs 26,000 crore worth of Indian stocks in November, a slowdown from October’s Rs 94,000 crore. FII buying through the primary market continued. A weaker Q2 GDP and valuations have made the market outlook uncertain. A Santa Claus rally is uncertain, and FII inflows may resume only after further market correction.

Nifty futures start the December series with a higher OI base of Rs 30,800 crore. Rollovers are at 79%, higher than the three-month average. Market-wide futures OI is at Rs 4.4 lakh crore, and rollovers are at 89%. Bank Nifty rollovers are at 76.8%, above the three-month average. Nuvama expects Nifty to trade in a range of 23,450-25,000 with heightened volatility.

FDI equity inflows into India rose 43.1% YoY to $13.6 billion in Q2 FY25. Total FDI grew 29.4% YoY to $19.8 billion. August saw the highest FDI of $6.3 billion in the quarter.

Home First Finance promoters are likely to sell a 14.7% stake via a block deal on Monday. The floor price is set at Rs 968, an 8% discount to the current market price. Kotak and Nomura are the brokers for the deal.

Dr Reddy’s Laboratories will be in the spotlight on Friday following the launch of toripalimab, an immune oncology drug designed to treat adults with a rare and aggressive form of head and neck cancer originating in the nasopharynx.

Overseas investors are identifying opportunities in India despite significant outflows. Notable inflows have been seen in industrials, healthcare, and telecommunication stocks. Prime Minister Modi’s push for manufacturing and increases in telecom prices are contributing factors. Financial stocks have been less attractive due to narrowing margins and asset quality concerns. Overall market trends indicate sector-specific investments are prominent.